Telix Pharmaceuticals Limited ADR (TLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Sales | 516,682 | 333,892 |
| Cost of Goods | 180,447 | 125,012 |
| Gross Profit | 336,235 | 208,881 |
| Operating Expenses | 282,501 | 198,368 |
| Operating Income | 54,181 | 10,524 |
| Interest Expense | 24,367 | 9,150 |
| Other Income | 7,166 | 677 |
| Pre-tax Income | 36,980 | 2,051 |
| Income Tax | 4,049 | -1,411 |
| Net Income Continuous | 32,932 | 3,462 |
| Net Income | $32,932 | $3,462 |
| EPS Basic Total Ops | 0.10 | 0.01 |
| EPS Basic Continuous Ops | 0.10 | 0.01 |
| EPS Diluted Total Ops | 0.10 | 0.01 |
| EPS Diluted Continuous Ops | 0.10 | 0.01 |
| EPS Diluted Before Non-Recurring Items | 0.10 | 0.01 |
| EBITDA(a) | $59,471 | $15,004 |